Position in BIIB
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$670,002
New position
Shares Held
3,101
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#518
of 1,036 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Charles Schwab Trust Co holds $19,134,040 across 8 Drug Manufacturers - General names. BIIB ranks #6 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
31,692 | $7,974,974 | |
| 2 | JNJ |
Johnson & Johnson
|
15,446 | $3,922,820 | |
| 3 | AMGN |
Amgen Inc
|
7,464 | $2,702,863 | |
| 4 | LLY |
ELI LILLY & Co
|
1,832 | $2,197,355 | |
| 5 | MRK |
Merck & Co., Inc.
|
8,250 | $1,060,125 | |
| 6 | BIIB |
Biogen Inc.
This page
|
3,101 | $670,002 | |
| 7 | PFE |
Pfizer Inc
|
16,129 | $388,386 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,775 | $217,515 |
All Filings in BIIB
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $670,002 | 3,101 | Shares | Sole | 2026-07-10 | |
| No filing history on record for this holder in this stock. | ||||||